I'm also not saying that's not what's happening; could easily be a hopeful acquirer.... it could also be people in one or more governments getting wind of those governments' plans for leronlimab... they're notoriously leaky and avoid SEC issues like insider trading etc most of the time (maybe even moreso for those associated with a foreign government?).

It's definitely way outside of the pale... I can't recall the last stock I've seen run so far and so methodically for more than three days without a significant retest of supports.

I just want to be sure people realize that capital gains are only one factor here... the dividends on just ONE indication would be phenomenal at these prices. Giving those up would be unbelievably shortsighted.